Form 8-K - Current report:
SEC Accession No. 0001564590-17-020980
Filing Date
2017-11-02
Accepted
2017-11-02 07:30:26
Documents
3
Period of Report
2017-11-02
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K FOR RCT PRESS RELEASE mygn-8k_20171102.htm 8-K 32781
2 EX-99.1 mygn-ex991_6.htm EX-99.1 28459
3 GRAPHIC g2017110201004240415115.jpg GRAPHIC 4299
  Complete submission text file 0001564590-17-020980.txt   68406
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 171170734
SIC: 2835 In Vitro & In Vivo Diagnostic Substances